Brendan B. Springstubb - 03 Mar 2025 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
03 Mar 2025
Net transactions value
+$43,750
Form type
4
Filing time
05 Mar 2025, 17:28:37 UTC
Previous filing
14 Feb 2025
Next filing
10 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +6,842 $0.000000 6,842 03 Mar 2025 Direct F1, F2
transaction EVH Class A Common Stock Purchase $43,750 +5,000 +73% $8.75 11,842 04 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Springstubb pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest on the earlier of March 3, 2026, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date.